BIOREM Reports First Quarter Results 2024
BIOREM Reports Strong First Quarter Financial Results and Continued Growth in Order Backlog BIOREM today announced results for the three month period […]
Author: biorem_admin
BIOREM Reports 2021 Financial Results
BIOREM Reports 2021 Financial Results BIOREM today announced its results for the three and twelve-month periods ended December 31, 2021. BIOREM’s complete […]
BIOREM Announces Several Orders Totalling $9.2 Million and Order Backlog of $34.6 Million
BIOREM Announces Several Orders Totalling $9.2 Million and Order Backlog of $34.6 Million GUELPH, ON, February 2nd, 2022 /CNW/ – BIOREM Inc. […]
Closing of Transaction to Purchase Common Shares for Cancellation
Closing of Transaction to Purchase Common Shares for Cancellation BIOREM is pleased to announce that it has completed the transaction to purchase […]
Third Quarter 2021 Financial Results
BIOREM Reports Third Quarter 2021 Financial Results BIOREM today announced its results for the three and nine-month periods ended September 30, 2021. […]
Novel Application of BIOREM’s Biological Reactors
Novel Application of BIOREM’s Biological Reactors to a New Market Segment BIOREM today announced a new order for an advanced biological system […]
Shareholders Approve Purchase for Cancellation of Common Shares Held by TPFG
BIOREM today announced that at the special meeting of shareholders held on September 16, 2021 the shareholders approved the purchase for cancellation […]
BIOREM Announces Proposed Purchase for Cancellation of Common Shares Held by TPFG Environment Investment Limited
GUELPH, ON, Aug. 5, 2021 /CNW/ – BIOREM Inc. (TSXV: BRM) (“Biorem” or “the Company”) today announced that its independent directors have approved, subject to […]
BIOREM Reports Second Quarter 2021 Financial Results
GUELPH, ON, July 28, 2021 /CNW/ – BIOREM Inc. (TSXV: BRM) (“Biorem” or “the Company”) today announced its results for the three […]
BIOREM Reports First Quarter 2021 Financial Results
GUELPH, ON, May 19, 2021 /CNW/ – BIOREM Inc. (TSXV: BRM) (“Biorem” or “the Company”) today announced results for the three month period ended March 31, 2021. […]